<< Back | Compounding News Home
Oxytocin: Help for Bonding Issues, Autism, Addiction, and Other Problems!

 Oxytocin has traditionally been used during labor to help with childbirth and after delivery to support milk letdown. However, the understanding of oxytocin’s function has expanded dramatically to reveal the capacity to modify human social behavior ranging from bonding and sexual activity to autism and addiction. Oxytocin induces a general sense of well-being including calm, improved social interactions, increased trust, and reduced fear. Oxytocin has the potential to enhance interpersonal relationships and individual well-being, and may help with disorders characterized by persistent fear, repetitive behavior, reduced trust and avoidance of social interactions. Oxytocin isn’t well absorbed orally, and traditionally has been administered as an IV. However, we can compound oxytocin nasal spray. Here are some of the problems discussed in the medical literature as having improved after treatment with oxytocin nasal spray:
• Male Sexual Function
• Autism Spectrum Disorder
• Migraine
• Post-Traumatic Stress Disorder (PTSD)
• Weight Management
• Addiction/Substance Use Disorders
 
   Intranasal oxytocin has a low risk of side effects, according to a systematic review of 38 randomized controlled studies conducted between 1990 and 2010.
 
Our pharmacy can compound oxytocin by prescription as a nasal spray, lozenge (troche), or vaginal cream or gel to make it easy to use. We make it more convenient for our patients to take their medicine! Our pharmacist will be happy to answer your healthcare questions, and will work with you and your doctor to customize medications to meet your unique needs.

References

J Affect Disord. 2011 Apr;130(1-2):1-9.
J Sex Med. 2012 May;9(5):1407-10.
J Sex Med. 2008 Apr;5(4):1022-4.
BMC Psychiatry. 2012; 12: 110. Published online 2012 August 13.
12th Annual International Meeting for Autism Research (IMFAR).  
Abstract 122.007. Presented May 3, 2013.

2013 International Headache Congress. Abstract P59.
Eur J Psychotraumatol. 2017 Apr 11;8(1):1302652.
Front Endocrinol (Lausanne). 2015; 6: 119.
Neuroendocrinology. 2018;107(1):91-104.
Behav Pharmacol. 2016 Dec;27(8):640-648.
Psychoneuroendocrinology. 2011 Sep;36(8):1114-26.


Copyright © 2007 - 2018, Storey Marketing. All rights reserved.